Leishmaniasis–human immunodeficiency virus (HIV) coinfection can manifest itself as
tegumentary or visceral leishmaniasis. Almost 35 countries have reported autochthonous …

Visceral leishmaniasis (VL) is caused by Leishmania donovani and Leishmania infantum.
The burden of VL is concentrated in tropical and subtropical areas; however, HIV infection …

Following the HIV epidemic, several countries have reported co-infections of Leishmania
with HIV. Co-infection with these two pathogens results in rapid disease progression, more …

Herein we review the particular aspects of leishmaniasis associated with HIV infection. The
data in this review are mainly from papers identified from PubMed searches and from papers …

Visceral leishmaniasis (VL) is a vector-borne parasitic disease targeting tissue
macrophages. It is among the most neglected infectious diseases. Classical manifestations …

Since the beginning of the HIV burden, Visceral Leishmaniasis (VL)/HIV co-infection has
been diagnosed not only in areas where VL is endemic (Latin America, India, Asia, Southern …

Background Tegumentary leishmaniasis (TL) is a disease of skin and/or mucosal tissues
caused by Leishmania parasites. TL patients may concurrently carry other pathogens, which …

The Leishmaniases are a group of diseases transmitted to humans by the bite of a sandfly,
caused by protozoan parasites of the genus Leishmania. Various Leishmania species infect …

Visceral leishmaniasis (VL) is a severe disease caused by protozoa of the genus
Leishmania that usually affects immunocompetent hosts in endemic areas [1, 2]. Since the …

To date, most Leishmania and human immunodeficiency virus (HIV) coinfection cases
reported to WHO come from Southern Europe. Up to the year 2001, nearly 2,000 cases of …